Rozy Kamal

Dr. Rozy Kamal


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2015 in Nutrition and Cancer
Verified
Journal Article
Closed access
SWSohini Walia
Sohini Walia
RKRozy Kamal
Rozy Kamal
SKSarbjit Singh Kanwar
Sarbjit Singh Kanwar
DDDavinder Kumar Dhawan
Davinder Kumar Dhawan
The present study was undertaken to assess the effects of potential probiotics in regulating the activity of cyclooxygenase-2 (COX-2) along with other morphological and histological analysis during 1,2-dimethylhydrazine (DMH) induced colon carcinogenesis in rats. The rats were divided into 6 groups viz., normal control, Lactobacillus plantarum (AdF10) treated, Lactobacillus rhamnosus GG (LGG) treated, DMH treated, AdF10 + DMH treated and LGG + DMH treated. Probiotics were supplemented to rats at dose levels of 2 × 1010 cells per day for 6 days in a week. All the treatments were continued for a period of 16 wk. DMH treatment resulted in a statistically significant increase in the levels of total sialic acid (TSA). However, on supplementation with probiotics, a significant reduction in TSA was observed. DMH treatment brought about a significant increase in the expression of COX-2. But, supplementation of probiotics brought down the protein expression to moderate level. Further, supplementation with probiotics was also able to reduce tumor incidence, tumor multiplicity and average tumor size. Therefore, treatment with probiotics has the potential of providing protection against colon cancer by suppressing the COX-2 expression as one of the protective mechanisms.

9 February 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
SWSohini Walia
Sohini Walia
RKRozy Kamal
Rozy Kamal
DDD. K. Dhawan
D. K. Dhawan
SKS. S. Kanwar
S. S. Kanwar

28 September 2023 in Advanced Healthcare Materials
Verified
Journal Article
Open access
MKManja Kubeil
Manja Kubeil
YSYota Suzuki
Yota Suzuki
Maria Antonietta CasulliMaria Antonietta Casulli
Maria Antonietta Casulli
RKRozy Kamal
Rozy Kamal
THTakeshi Hashimoto
Takeshi Hashimoto
HSHolger STEPHAN
Holger STEPHAN
Nanogels open up access to a wide range of applications and offer among others hopeful approaches for use in the field of biomedicine. This review provides a brief overview of current developments of nanogels in general, particularly in the fields of drug delivery, therapeutic applications, tissue engineering, and sensor systems. Specifically, cyclodextrin (CD)‐based nanogels are important because they have exceptional complexation properties and are highly biocompatible. Nanogels as a whole and CD‐based nanogels in particular can be customized in a wide range of sizes and equipped with a desired surface charge as well as containing additional molecules inside and outside, such as dyes, solubility‐mediating groups or even biological vector molecules for pharmaceutical targeting. Currently, biological investigations are mainly carried out in vitro, but more and more in vivo applications are gaining importance. Modern molecular imaging methods are increasingly being used for the latter. Due to an extremely high sensitivity and the possibility of obtaining quantitative data on pharmacokinetic and pharmacodynamic properties, nuclear methods such as single photon emission computed tomography (SPECT) and positron emission tomography (PET) using radiolabeled compounds are particularly suitable here. The use of radiolabeled nanogels for imaging, but also for therapy, is being discussed.

1 January 2014 in Journal of Environmental Pathology, Toxicology and Oncology
Verified
Journal Article
Closed access
PDF file
RKRozy Kamal
Rozy Kamal
CPChatterji Piyali
Chatterji Piyali
VCVijayta Dani Chadha
Vijayta Dani Chadha
This study optimized the radiolabeling of cisplatin with technetium-99m (99mTc) and evaluated its biodistribution in an experimental model of lung carcinogenesis. The percentage labeling of cisplatin with 99mTc was assessed using an ascending chromatographic technique. For biodistribution studies, male rats were divided into 2 groups. The control group received normal saline intratracheally, whereas the treatment group received intratracheal administration of carcinogen 7,12-dimethylbenz(a)anthracene (DMBA) at a dose of 20 mg/kg body weight. The resulting radiopharmaceutical (99mTc-cisplatin) showed 98% labeling efficiency and was found to be stable for up to 6 hours both in both serum and saline under normal conditions. The blood clearance of the 99mTc-cisplatin followed a biphasic release pattern whereby a fast-release phase was observed at 35 seconds and a slow-release phase was observed after 30 minutes of drug administration. The biodistribution studies of control and treated animals revealed high uptake of 99mTc-cisplatin by the liver and slow excretion via the kidneys. However, a time-dependent increase in the lung-to-muscle specific uptake ratio was observed in DMBA-treated rats. The study concluded that 99mTc-cisplatin possesses selectivity toward cancerous lung tissue and can be explored further for its diagnostic potential in the detection of lung cancer and the evaluation of treatment response.

15 July 2014 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
RKRozy Kamal
Rozy Kamal
SBS. C. Bansal
S. C. Bansal
NKN. Khandelwal
N. Khandelwal
DRD. V. Rai
D. V. Rai
DDDevinder Kumar Dhawan
Devinder Kumar Dhawan

1 January 2016 in Journal of Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
DDDk Dhawan
Dk Dhawan
RKRozy Kamal
Rozy Kamal